How tumors evade immunotherapy: DDB1 sends PD-L1 into nuclei, driving anti-PD-1 resistance
Immune checkpoint blockade has reshaped modern oncology, but its success remains uneven. Drugs that disrupt the PD-1/PD-L1 pathway can produce ...
Immune checkpoint blockade has reshaped modern oncology, but its success remains uneven. Drugs that disrupt the PD-1/PD-L1 pathway can produce ...
In a groundbreaking study published in the British Journal of Cancer, researchers have illuminated the complex and detrimental impact of ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine